GlassScriptPhysician profile
Nitin Dilip Joshi
NPI 1154541423
$2,286.51
in general payments reported to CMS, 2019-2025
19 companies · $14.91 in 2025
See the full distribution for Hematology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $276 · 2020: $1,069 · 2021: $346 · 2022: $111 · 2023: $290 · 2024: $180 · 2025: $14.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $485.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rigel Pharmaceuticals, INC. | $1,119.47 | 2020-2023 | Tavalisse, Rezlidhia |
| Pfizer INC. | $385.85 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $124.99 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $119.96 | 2019 | |
| Seagen INC. | $114.48 | 2021-2023 | Tukysa |
| Csl Behring | $65.56 | 2024 | Kcentra |
| Celgene Corporation | $51.13 | 2024 | Pomalyst, Reblozyl |
| Pharmacyclics LLC, An Abbvie Company | $45.49 | 2021-2023 | Imbruvica, Epkinly |
| Janssen Biotech, INC. | $38.00 | 2019-2020 | |
| Coherus Oncology, INC. | $32.44 | 2022-2023 | |
| Daiichi Sankyo INC. | $28.02 | 2023 | |
| Acrotech Biopharma INC. | $27.86 | 2021 | |
| Eisai INC. | $23.96 | 2024 | |
| Novartis Pharmaceuticals Corporation | $23.61 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $21.61 | 2024 | Opdivo |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $19.06 | 2021 | |
| Gilead Sciences, INC. | $17.69 | 2024 | |
| Abbvie INC. | $14.91 | 2025 | |
| Janssen Pharmaceuticals, INC | $12.42 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nitin Joshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.